Authors: Steven Rosen, M.D., John Barsa, M.D., Timothy Deer, M.D., Elmer Dunbar, M.D., Gopala Dwarakanath, M.D., Gurpreet Padda, M.D. and Richard Rauck, M.D.
Published: NANS 12/4/08
Poster presents data on 21 patients with both spinal cord stimulators and the Prometra pump. 197 refill visits are documented with a 98.6% accuracy for drug delivery. Differences between patients with pump only therapy versus dual device therapy are noted, such as differences between morphine dosing levels. No significant differences were noted, including differences between complication rates. Efficacy data is also illustrated, including ODI, VAS, and NRS. VAS and NRS improvements were significant at 1, 6, and 12 month periods. No significantly different outcomes were noted in pump-only versus dual therapy patients.
